A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs

Published:2014-03-17 Issue:1 Volume:8 Page:19-30
ISSN:1872-3128
Container-title:Drug Metabolism Letters
language:en
Short-container-title:DML

Author:

Moghaddam Mehran,Tang Yang,O’Brien Zhihong,Richardson Samantha,Bacolod Maria,Chaturedi Prasoon,Apuy Julius,Kulkarni Ashutosh

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Biochemistry, medical,Clinical Biochemistry,Pharmaceutical Science

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug development of covalent inhibitors;Overcoming Obstacles in Drug Discovery and Development;2023

2. Approaches to mitigate the risk of serious adverse reactions in covalent drug design;Expert Opinion on Drug Discovery;2020-10-19

3. Cov_FB3D: A De Novo Covalent Drug Design Protocol Integrating the BA-SAMP Strategy and Machine-Learning-Based Synthetic Tractability Evaluation;Journal of Chemical Information and Modeling;2020-04-01

4. Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design;Journal of Medicinal Chemistry;2019-07-23

5. Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans;Drug Metabolism and Disposition;2018-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP